IPCA LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 524494     NSE : IPCALAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 25,2022
Price(EOD): β‚Ή 938.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 23,797.06 Cr
Value of β‚Ή 1 Lac invested in IPCA LABORATORIES
on May 25,2017 (price: β‚Ή 244.03)

β‚Ή 1 L

β‚Ή 3.84 L

1W : -2.8% 1M : -6.1% 1Y : -14.2%
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
IPCA LABORATORIES -2.8% -6.1% -14.2%
SUN PHARMACEUTICAL INDUSTRIES 3% 1.3% 31.9%
DIVIS LABORATORIES -16.2% -20.1% -9.3%
DR REDDYS LABORATORIES 9.6% 4.7% -16.9%
CIPLA 3.6% 1.9% 4.7%
GLAND PHARMA -11.4% -16.5% -9.6%
PIRAMAL ENTERPRISES -4.4% -14.3% 4.7%
CADILA HEALTHCARE 8.2% 7.4% -39.9%
TORRENT PHARMACEUTICALS 1.7% -3.5% -4.6%

FUNDAMENTAL ANALYSIS OF IPCA LABORATORIES

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights πŸ’‘ IPCALAB is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF IPCA LABORATORIES

 
Valuation Score
[As on : May 25,2022 ]

Ratio Consolidated
P/E
P/B
P/S
10.44
P/E Calculated based on EPS of 89.87
[ Mar2021 - Consolidated Results ]

2.53
P/B Calculated based on Book Value of 370.65
[ Mar2021 - Consolidated Results ]

4.08
P/S Calculated based on Revenues of 5829.79 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF IPCA LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
10%
55%
68%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF IPCA LABORATORIES


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

IPCA LABORATORIES vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF IPCA LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.05
0.12
0.14
0.1
0.05
0.13
0.15
0.11
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF IPCA LABORATORIES

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF IPCA LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-9.88%
-28.75%
-34.95%
-30.76%
15.65%
-4.19%
-12.89%
-14%
QtrlyTrend
-6
Latest Qtr: Mar2022
Quarterly Result Analysis →


IPCA LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE LARGE MIDCAP -2% -8.1% 6.8%
S&P BSE 200 -2.1% -8.2% 6.8%
S&P BSE 250 LARGEMIDCAP -2.2% -8.2% 6.9%
S&P BSE 500 -2.3% -8.7% 6.8%
S&P BSE ALLCAP -2.5% -9% 7.1%
S&P BSE HEALTHCARE -3.1% -10.6% -9.5%
S&P BSE 150 MIDCAP -3.6% -10.5% 6.5%
S&P BSE MID CAP -3.7% -11.6% 2.4%
S&P BSE 400 MIDSMALLCAP -4% -11.9% 6.1%
S&P BSE MIDSMALLCAP -4.3% -13% 6.1%
NSE Indices1W1M1Y
NIFTY 200 -2.1% -8.2% 6.7%
NIFTY 500 -2.4% -8.8% 6.7%
NIFTY PHARMA -2.6% -7.6% -10.2%
NIFTY HEALTHCARE -2.8% -10% -8.1%
NIFTY LARGE MIDCAP 250 -2.9% -9.3% 6.8%
NIFTY500 MULTICAP 50:25:25 -3.1% -10.4% 6.7%
NIFTY MIDCAP150 -4% -10.9% 6.7%
NIFTY FREE MIDCAP 100 -4.2% -11.2% 6.8%
NIFTY MIDCAP150 QUALITY 50 -4.3% -10.8% 1.7%
NIFTY MID SMALL400 -4.3% -12.3% 6.5%

You may also like the below Video Courses


FAQ about IPCA LABORATORIES


Is IPCA LABORATORIES good for long term investment?

As on May 25,2022, the Fundamentals of IPCA LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of IPCA LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is IPCA LABORATORIES UnderValued or OverValued?

As on May 25,2022, IPCA LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of IPCA LABORATORIES ?

As on May 25,2022, the Intrinsic Value of IPCA LABORATORIES is Rs. 604.54 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 852.60
Fair Value [Median EV / Sales Model] : Rs. 604.54
Fair Value [Median Price / Sales Model] : Rs. 557.00
Median Fair Value of IPCA LABORATORIES : Rs. 604.54

Is IPCA LABORATORIES trading at a Premium or Discount?

As on May 25,2022, IPCA LABORATORIES is trading at a Premium of 55% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z